双模式的ClfA向DARPin生物药物可以防止各种抗甲素的黄金葡萄球菌菌株
bioRxiv : the preprint server for biology
|January 16, 2026
概括
研究人员开发了一种双模式的生物药物,以阻断Staphylococcus aureus的凝聚因子A (ClfA) 粘附. 这一策略针对暴露和隐藏的结合部位,抑制细菌入侵和预防感染.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 黄金葡萄球菌使用凝聚因子A (ClfA) 结合纤维素原,促进侵入性感染.
- ClfA具有双结合接口,一个暴露的低亲和位点和一个切割暴露的高亲和位点,限制了抗体的有效性.
研究的目的:
- 开发一种针对两种ClfA结合接口的双模式抑制策略.
- 设计能够同时阻断ClfA-纤维素原相互作用的新生物药物.
主要方法:
- 使用无细胞点击显示和动力学引导的亲和力成熟.
- 工程设计的安基林重复蛋白 (DARPin) -v-融合生物.
主要成果:
- 开发了能同时阻断两种ClfA纤维素原结合接口的聚变生物制剂.
- 抑制了ClfA-纤维素因子相互作用,防止了耐美西林的金黄色结,并中和了临床的ClfA变体.
- 在小鼠细菌病模型中赋予Fc独立的保护.
结论:
- 双模式抑制策略有效地准抗体难以处理的,强力激活的葡萄球菌粘合素.
- 工程生物药物显示出通过阻断关键的粘附机制来对抗金黄色细菌感染的潜力.
相关概念视频
Defense Against Bacterial Pathogens
2.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K
Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


